GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+15.08%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$2.54B
AUM Growth
+$2.54B
(+1.7%)
Cap. Flow
-$198M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
27.59%
Holding
204
New
24
Increased
57
Reduced
106
Closed
17
Top Buys
| 1 |
Exact Sciences
EXAS
|
$27.9M |
| 2 |
ACV Auctions
ACVA
|
$18.3M |
| 3 |
Kura Sushi USA
KRUS
|
$17.5M |
| 4 |
HubSpot
HUBS
|
$15.3M |
| 5 |
SharkNinja
SN
|
$14.7M |
Top Sells
| 1 |
Zeta Global
ZETA
|
$84.6M |
| 2 |
SMAR
Smartsheet Inc.
SMAR
|
$19.6M |
| 3 |
Sprout Social
SPT
|
$19.6M |
| 4 |
Castle Biosciences
CSTL
|
$18.1M |
| 5 |
Magnite
MGNI
|
$17M |
Sector Composition
| 1 | Technology | 35.52% |
| 2 | Healthcare | 22.32% |
| 3 | Industrials | 15.28% |
| 4 | Consumer Discretionary | 8.56% |
| 5 | Communication Services | 6.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Cytosorbents Corp
CTSO
$59.6M
| $3.14M | 0.12% |
2,094,882
-568,929
| -21% | -$853K |
|
152
Acadia Healthcare
ACHC
$2.15B
| $3.1M | 0.12% |
48,890
-16,798
| -26% | -$1.07M |
|
153
Orion Group Holdings
ORN
$286M
| $3.1M | 0.12% |
536,977
+422,387
| +369% | +$2.44M |
|
154
Okta
OKTA
$15.8B
| $3.05M | 0.12% |
41,029
-681
| -2% | -$50.6K |
|
155
908 Devices
MASS
$214M
| $2.99M | 0.12% |
861,433
-58,196
| -6% | -$202K |
|
156
Rogers Corp
ROG
$1.39B
| $2.96M | 0.12% |
26,206
-258
| -1% | -$29.2K |
|
157
Universal Technical Institute
UTI
$1.5B
| $2.77M | 0.11% |
170,559
-14,275
| -8% | -$232K |
|
158
Summit Therapeutics
SMMT
$17.5B
| $2.76M | 0.11% |
+126,098
| New | +$2.76M |
|
|
PRSU
159
Pursuit Attractions and Hospitality, Inc.
PRSU
$1.05B
| $2.62M | 0.1% |
73,152
-117,303
| -62% | -$4.2M |
|
160
Nextracker
NXT
$9.88B
| $2.59M | 0.1% |
+69,148
| New | +$2.59M |
|
161
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.46B
| $2.57M | 0.1% |
+74,568
| New | +$2.57M |
|
162
Stevanato
STVN
$6.36B
| $2.32M | 0.09% |
+115,983
| New | +$2.32M |
|
163
Vericel Corp
VCEL
$1.69B
| $2.3M | 0.09% |
+54,366
| New | +$2.3M |
|
164
Taysha Gene Therapies
TSHA
$791M
| $2.29M | 0.09% |
1,139,899
+330,208
| +41% | +$664K |
|
165
Cellebrite
CLBT
$4.04B
| $2.26M | 0.09% |
134,138
-129,039
| -49% | -$2.17M |
|
166
Radware
RDWR
$1.06B
| $2.23M | 0.09% |
99,987
-26,042
| -21% | -$580K |
|
|
BCYC
167
Bicycle Therapeutics
BCYC
$492M
| $2.19M | 0.09% |
+96,916
| New | +$2.19M |
|
168
SPX Corp
SPXC
$9.03B
| $2.19M | 0.09% |
13,724
-38,027
| -73% | -$6.06M |
|
169
Vicor
VICR
$2.27B
| $2.04M | 0.08% |
48,518
+2,406
| +5% | +$101K |
|
170
AvePoint
AVPT
$3.41B
| $2.04M | 0.08% |
173,011
+136,188
| +370% | +$1.6M |
|
171
Arcturus Therapeutics
ARCT
$467M
| $2.01M | 0.08% |
86,416
-258,133
| -75% | -$5.99M |
|
172
First Solar
FSLR
$21.6B
| $1.62M | 0.06% |
6,482
-8,204
| -56% | -$2.05M |
|
173
Extreme Networks
EXTR
$2.87B
| $1.51M | 0.06% |
100,594
-292,711
| -74% | -$4.4M |
|
174
Tetra Tech
TTEK
$9.45B
| $715K | 0.03% |
15,155
-16,190
| -52% | -$764K |
|
175
Goosehead Insurance
GSHD
$2.1B
| $636K | 0.03% |
7,118
-3,015
| -30% | -$269K |
|